Fecal Microbiota Transplant for Anorexia Nervosa

Starting soon · Not applicable · Has a placebo group

Conditions studied: Anorexia Nervosa Restricting Type, Anorexia Nervosa, Anorexia in Adolescence, Anorexia in Children, Anorexia

In brief

The purpose of this pilot randomized-controlled trial is to determine whether Fecal Microbiota Transplant (FMT) treatment demonstrates feasibility, acceptability, and prelinary effectiveness among patients with anorexia nervosa (AN). Specifically, the investigators aim to compare changes in weight, gut microbiome, urine, blood biomarkers and mood symptoms between participants receiving the FMT intervention and placebo.

Key facts

Study ID

NCT06593366

Run by

Hamilton Health Sciences Corporation

People needed

20

Starts

2026-06-01

Expected to finish

2027-06-01

Last updated by the study team

2026-05-27

Who can join

Age: 12 and older, up to 17. Sex: female. Healthy volunteers: not accepted.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.